Profile data is unavailable for this security.
About the company
Hangzhou AGS MedTech Co Ltd is a China-based company mainly engaged in the research, development, production and sales of endoscopic minimally invasive diagnostic and therapeutic devices. The Company's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.
- Revenue in CNY (TTM)529.86m
- Net income in CNY235.79m
- Incorporated2010
- Employees592.00
- LocationHangzhou AGS MedTech Co LtdBuilding 5 and Building 6No. 597 Kangxin Road, Yuhang DistrictHANGZHOU 311106ChinaCHN
- Phone+86 57 188775216
- Fax+86 57 187671225
- Websitehttp://www.bioags.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TINAVI Medical Technologies Co Ltd | 199.48m | -175.09m | 3.66bn | 354.00 | -- | 2.91 | -- | 18.02 | -0.3862 | -0.3862 | 0.4396 | 2.75 | 0.1283 | 1.50 | 6.22 | 563,494.90 | -11.26 | -7.86 | -12.14 | -9.07 | 69.95 | 73.58 | -87.77 | -50.09 | 2.99 | -- | 0.156 | -- | 34.48 | 10.63 | -41.42 | -- | 51.87 | -- |
| Sino Medical Sciences Technology Inc | 361.15m | -20.92m | 3.83bn | 652.00 | -- | 4.61 | -- | 10.48 | -0.051 | -0.051 | 0.8809 | 2.00 | 0.3109 | 1.34 | 24.46 | 553,914.40 | -1.62 | -4.21 | -1.95 | -4.71 | 58.14 | 70.96 | -5.22 | -15.76 | 1.55 | -- | 0.1442 | -- | 77.99 | -2.04 | 75.59 | -- | -7.30 | -- |
| Shanghai Sanyou Medical Co Ltd | 385.98m | 58.83m | 4.43bn | 466.00 | 78.05 | 2.31 | -- | 11.46 | 0.228 | 0.228 | 1.53 | 7.71 | 0.1699 | 0.5891 | 2.20 | 828,288.80 | 3.29 | 9.42 | 3.86 | 10.85 | 71.52 | 87.15 | 19.34 | 29.78 | 3.35 | -- | 0.0291 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
| Hangzhou Ags Medtech Co Ltd | 529.86m | 235.79m | 4.47bn | 592.00 | 18.89 | 1.98 | -- | 8.40 | 4.07 | 4.07 | 9.16 | 38.92 | 0.3775 | 3.36 | 13.43 | 895,039.90 | 16.80 | -- | 17.73 | -- | 70.24 | -- | 44.50 | -- | 24.45 | -- | 0.0054 | -- | 37.09 | -- | 49.87 | -- | -- | -- |
| SWS Hemodialysis Care Co Ltd | 659.16m | 154.15m | 4.53bn | 881.00 | 28.75 | 2.58 | -- | 6.72 | 0.7148 | 0.7148 | 3.06 | 7.97 | 0.3351 | 2.11 | 5.56 | 748,197.70 | 7.71 | -- | 8.68 | -- | 50.81 | -- | 23.00 | -- | 15.96 | -- | 0.0089 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Hubei Huaqiang High-Tech Co Ltd | 502.24m | 4.95m | 4.54bn | 706.00 | 909.53 | 1.08 | -- | 8.97 | 0.0144 | 0.0144 | 1.46 | 12.15 | 0.0993 | 1.83 | 0.7415 | 711,388.30 | 0.0978 | 3.82 | 0.1078 | 4.62 | 11.73 | 26.28 | 0.9853 | 14.29 | 7.84 | -- | 0.0043 | 20.55 | -2.21 | -5.08 | -88.36 | -40.15 | -12.17 | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 1.02bn | 125.32m | 4.75bn | 1.67k | 38.59 | 2.87 | -- | 4.74 | 1.11 | 1.11 | 9.07 | 14.98 | 0.5447 | 6.00 | 4.59 | 609,805.40 | 6.69 | 16.35 | 7.46 | 19.26 | 31.13 | 41.19 | 12.28 | 21.62 | 3.85 | -- | 0.0201 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
| Qingdao NovelBeam Technology Co Ltd | 439.81m | 135.69m | 5.08bn | 797.00 | 36.67 | 3.75 | -- | 11.35 | 1.12 | 1.12 | 3.62 | 10.95 | 0.3138 | 1.08 | 4.50 | 551,832.80 | 9.45 | 14.67 | 10.07 | 16.63 | 62.54 | 62.32 | 30.11 | 34.15 | 11.88 | -- | 0.0039 | 33.55 | -1.31 | 18.58 | -20.19 | 21.71 | 10.45 | -- |
| Xiangyu Medical Co Ltd | 770.75m | 227.62m | 5.31bn | 1.82k | 22.73 | 2.49 | -- | 6.83 | 1.45 | 1.45 | 4.90 | 13.23 | 0.2968 | 1.08 | 18.95 | 423,724.10 | 8.80 | 11.18 | 10.79 | 13.12 | 67.66 | 66.78 | 29.64 | 32.69 | 1.89 | -- | 0.1247 | 27.33 | 52.46 | 15.72 | 81.03 | 23.11 | 132.76 | -- |
Data as of Jun 20 2024. Currency figures normalised to Hangzhou AGS MedTech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
38.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 1.24m | 9.59% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 957.40k | 7.41% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 483.95k | 3.75% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023 | 431.88k | 3.34% |
| Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 381.32k | 2.95% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 363.89k | 2.82% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 315.85k | 2.45% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 310.90k | 2.41% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 309.83k | 2.40% |
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 240.27k | 1.86% |
More ▼
Data from 31 Dec 2023 - 13 Jun 2024Source: FactSet Research Systems Inc.
